Navigation Links
Hormone Pills in Menopause May Carry Gallstone Side Effects
Date:3/19/2013

TUESDAY, March 19 (HealthDay News) -- Taking estrogen pills increases a menopausal woman's risk of needing gallbladder surgery to treat complications of gallstones, according to a new study.

But there does not appear to be an increased risk for women who take estrogen through skin patches or gels, called transdermal methods.

The study appears March 18 in the CMAJ (Canadian Medical Association Journal).

Researchers analyzed data gathered from more than 70,000 women in France between 1992 and 2008. In France, transdermal hormone therapy is preferred, while oral hormone therapy (pills or tablets) tends to be favored in North America and the United Kingdom, a journal news release noted.

"Complicated gallstone disease should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with menopausal hormone therapy," said Dr. Antoine Racine, of the French National Institute for Health and Medical Research and Paris-Sud University, and colleagues.

These findings support current recommendations for minimizing doses and duration of hormone therapy to treat symptoms of menopause, Dr. Bette Liu, of the faculty of medicine at the University of New South Wales, in Sydney, Australia, wrote in an accompanying editorial.

If hormone therapy is necessary, skin patches or gels may cause fewer side effects than pills or tablets, she added.

"Unfortunately there are no large clinical trials comparing transdermal and oral therapies, and such trials will probably never be conducted," Liu wrote. "Evidence to guide recommendations on the best route of hormone administration for individual women and prescribers will thus be limited to the growing volume of observational data. These data suggest that the overall risk-benefit of transdermal menopausal hormone therapy makes it a more attractive option than oral therapies."

Although the study showed a link b
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Study examines outcomes of screening mammography for age, breast density, hormone therapy
2. Blood levels of fat cell hormone may predict severity of migraines
3. Can hormone help treat multiple sclerosis long-term?
4. Procedure Lowers Hunger Hormone to Help Obese Lose Weight
5. Stress hormone foreshadows postpartum depression in new mothers
6. Thyroid hormones reduce damage and improve heart function after myocardial infarction in rats
7. Renew Health and Wellness, a Hormone Replacement and Weight Loss Clinic Based in St. Louis, MO, Announces the Addition of Tara Smith, NP, to Their Staff of Professionals
8. Could Duration of Prostate Cancer Hormone Therapy Be Halved?
9. Anti-Muellerian hormone predicts IVF success
10. Study finds hormones can change the breasts genetic material
11. Test for hormone-disrupting chemicals gets global seal of approval
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Pills in Menopause May Carry Gallstone Side Effects
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has ... , The acquisition includes all of IBAM NA’s cyclotron sites and research and development ... robust regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... Programs, with accountability for overall performance of the company’s Medicare and Federal Employee ... of Cambia’s strategy to deliver better health for members. In this role, Scott ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Did you ... or Orange County looking for exceptional and affordable home care options which A-1 Home ... are just a few of the credentials A-1 Home Care Agency is ...
Breaking Medicine News(10 mins):Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3
... Institute of Medical Sciences (KIMS), a leading hospital here, ... accreditation that will// help it attract patients from abroad. ... the Australian Council for Health Care Standards International (ACHSI), ... extensive, week-long survey of KIMS facilities. KIMS has become ...
... from chronic asthma do not get proper treatment and ... ,Specialists at the Johns Hopkins Children’s Center and elsewhere ... the researchers say, because preventive therapy failure leads to ... strikes and to more complications and increased risk of ...
... tiny heating device that can be inserted inside the lungs ... or nose can help treat asthma, researchers conducting its// trial ... system in which the airways constrict making it hard to ... ,Though asthma can't be cured, it can be managed with ...
... senior and well-known scientist of America’s premier medical agency ... criminal conflict of interests.// ,Dr Trey Sutherland ... drug company as consulting fees as well as providing ... is said to have received $285,000 in payment for ...
... the anti-craving drug, Naltrexone may lessen cessation-related weight gain ... quit smoking appear //to benefit more than men. As ... on gender differences in nicotine addiction and in treatment. ... of the University of Chicago have added a drug ...
... hair-growth drug finasteride, taken by millions of balding men, ... test,// the standard screening test for prostate cancer, a ... men ranging in age from 40 to 60 years ... The Lancet and is scheduled to be published after ...
Cached Medicine News:Health News:Medication Not Available On Time To Inner-city Children 2Health News:Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening 2
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... OAKS, Calif. , July 30, 2015  Amgen (NASDAQ: ... Hassan , partner and managing director of Warburg Pincus LLC, ... are pleased to welcome Fred Hassan and the ... the Amgen Board," said Robert A. Bradway , chairman ... and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Corporation (Nasdaq: DNDN ) today reported results for ... quarter ended September 30, 2010 was $20.2 million compared to ... the nine months ended September 30, 2010 was $23.1 million ... 2009.   Revenue from sales of PROVENGE® (sipuleucel-T) ...
... EMERYVILLE, Calif., Nov. 3, 2010 Onyx Pharmaceuticals, ... results for the third quarter 2010. Onyx reported non-GAAP net ... the third quarter 2010 compared to non-GAAP net income of ... period in 2009. Non-GAAP net income excludes, among other items, ...
Cached Medicine Technology:Dendreon Reports Third Quarter 2010 Financial Results 2Dendreon Reports Third Quarter 2010 Financial Results 3Dendreon Reports Third Quarter 2010 Financial Results 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 2Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 3Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 5Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 6Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 7Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 8Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 9Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 10
... is synthesized by the parathyroid glands ... decreased extracellular calcium concentrations. PTH prevents ... decreasing calcium excretion by the kidney. ... PTH is rapidly degraded into 4 ...
... is produced in the adrenal cortex and, ... DHEA serves as a precursor in testosterone ... androgenic activity, estimated at ~10% that of ... and in adult women, DHEA is an ...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
... is a 32 kDa glycoprotein secreted by ... gland [1]. The structure of human TSH ... and placental gonadotropins, consisting of an a-subunit ... hormones and a unique beta-subunit, which confers ...
Medicine Products: